CXCR2 and cancer: CXCR2+ MDSCs were recruited to CXCL2- and MIF-expressing human bladder tumors and those tumor-associated MDSCs exhibited stronger suppression of T cells than the counterpart cells from the peripheral blood of cancer patients or healthy donors [250].